ESWI is delighted to present two events specifically dedicated to RSV:ย A Symposiumย on the Burden of RSV Disease (2023)ย and a one-day Summitย (2024). The idea for the events stem from the increased rates of RSV infections, and from the rapid pace of new technical and vaccine developments.
Respiratory Syncytial Virus (RSV) is a common virus that affects all age groups with varying clinical effects. The virus is transmitted easily through coughing and sneezing with droplets containing the virus. RSV disease is a major burden in infants and young children and older adults, causing hospitalisation and in acute cases, death.
Prevention and treatment options could be available soon as multiple clinical trials are being held and are showing a high efficacy. Therefore, ESWI believes in the importance of putting a spotlight on RSV โ and in particular- on the Science-and-Policy interface that would govern and guide future intervention strategies.
Following up on our 2021 Webinar โRSV in a COVID-19 eraโ, ESWI will be organising a live-streamed Symposium on the Burden of RSV Disease on 19th September 2023. Online attendance of the Symposium is free of charge but registration is mandatory.ย This will be followed by the RSV Summit in 2024 which will also look at immunisation and intervention strategies.